Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
United Therapeutics (UTHR) Slammed After Trial Fails to Meet Primary Endpoint
-
Deutsche Bank Downgrades United Therapeutics Corp. (UTHR) to Hold; Oral Approval Likelihood Lowered
-
Notable Analyst Rating Changes 04/29: (CL) (DISCA) (UIS) Upgraded; (RIMM) (OSK) (IM) Downgraded
-
Deutsche Bank Starts United Therapeutics Corp. (UTHR) at Buy; Attractive Risk/Reward into FREEDOM M
-
Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
-
Morning Movers 3/16: Beaten-Up Bank Stocks Up Again (C, BAC); SanDisk (SNDK) Drops On Negative Analyst Comments
-
Unusual 11 Mid-Day Movers 11/17: GTE, CTS, PHH, ARTG Higher; UTHR, DFT, BIDU, HIG Lower
-
Deutsche Bank Downgrades United Therapeutics (UTHR) to Hold
-
Deutsche Bank Initiates Coverage on United Therapeutics (UTHR) with a Buy
